comparemela.com

Latest Breaking News On - Investor relations corporate communications - Page 3 : comparemela.com

Zealand Pharma major shareholder announcement: Polar Capital

Zealand Pharma major shareholder announcement: Polar Capital
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

Copenhagen
Køavn
Denmark
Danish
Zealand-pharma
Anna-krassowska
Adam-lange
Investor-relations-corporate-communications
Polar-capital
Danish-capital-markets-act
Investor-relations

Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024

Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Denmark
Copenhagen
Køavn
Miami
Florida
Adam-steensberg
Zealand-pharma
Anna-krassowska
Investor-relations-corporate-communications
Goldman-sachs

Zealand Pharma to participate in upcoming healthcare

Zealand Pharma to participate in upcoming healthcare
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Copenhagen
Køavn
Denmark
Miami
Florida
United-states
New-york
Adam-steensberg
Zealand-pharma
Anna-krassowska
Investor-relations-corporate-communications
Goldman-sachs

Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca

HAMILTON, ON and BOSTON, May 29, 2024 /PRNewswire/ Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjugates as precision medicines,.

Canada
Boston
Massachusetts
United-states
Canadian
Amanda-cray
Us-securities-exchange-commission
Investor-relations-corporate-communications
Nasdaq
Us-securities-exchange
Fusion-pharmaceuticals
Astrazeneca

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.